Why biotech needs Europe and Europe nee...Its getting a little boring listening to conversations about the 2014-2020 budget. As citizens, were subjected to endless national bickering and point-scoring as national leaders look to secure their … more ➔
Nigel Sheail: Partnering for innovative he...Partnering and even open innovation is becoming increasingly important for our industry in a world where health systems are undergoing profound transformations. more ➔
When scientists have to strike at their ow...We all read with dismay but not a huge amount of surprise the October paper from French researchers led by Gilles-Eric Séralini on the two-year rat-feeding study looking at the effects of glyphosate-treated … more ➔
Regina Revilla/Emilio Munoz: The Importanc...Since the beginning of the year, there have been numerous government initiatives in the most advanced countries to implement and strengthen policies to support biotechnology. more ➔
When science makes you smileHello readers! You know, when you view the biotechnology landscape from a Brussels perspective, you can very easily get stuck looking at the bad bits meddling politicians, poor science reporting, … more ➔
Andrea Rappagliosi: Challenges and answers...During the last thirty years, healthcare expenditure has been growing much more rapidly than GDP in OECD countries, causing increasing concerns about the long-term sustainability of current trends. As … more ➔
Fixing Europe (again)Well ladies and gentlemen of the biotechnology community, welcome back after the silly season. I hope you had a nice one, whether it was in the sunny bit, the rainy bit or the bits that were on fire. … more ➔
Is Europe truly ready for a bioeconomy?Bioeconomy is the new health, and that is official. You only have to look at all the planning for Horizon 2020 and all the big words coming out of politicians at national and European levels to see that. … more ➔
Erik Bogsch: Biosimilars and biologics for...Twenty-eight percent of the products given marketing authorisation between November 2010 and October 2011 in the US and one-third of all the new drugs in the EU have biotechnological origins. And experts … more ➔
Solving the debt with biotechGood news! After some thinking, Ive solved the eurocrisis and saved national investment in biotechnology! As with most people who champion a single Europe, what is going to happen in the eurozone weighs … more ➔
